RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value: $1.195B (100.0% shares, 0.0% debt)

Holdings (27)

WVE WAVE LIFE SCIENCES LTD 22.1%
Value $264M Shares 7,512,049 Share Price $35.10 * Est. Cost/Share $16.44 Unrealized @ Report Date +77.3%
ASND ASCENDIS PHARMA A S 18.7%
Value $224M Shares 5,580,690 Share Price $40.06 Est. Cost/Share $17.96 Unrealized @ Report Date —
— AVEXIS INC 10.8%
Value $130M Shares 1,171,278 Share Price $110.67 Est. Cost/Share $31.86 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 6.3%
Value $74.97M Shares 455,173 Share Price $164.71 Est. Cost/Share $164.71 Unrealized @ Report Date —
IFRX INFLARX NV 5.0%
Value $60.25M Shares 2,876,080 Share Price $20.95 * Est. Cost/Share $17.97 Unrealized @ Report Date 0.0%
— BIOHAVEN PHARMACTL HLDG CO LTD 4.5%
Value $53.89M Shares 1,997,278 Share Price $26.98 Est. Cost/Share $25.00 Unrealized @ Report Date —
— ZOGENIX INC 3.8%
Value $45.87M Shares 1,145,268 Share Price $40.05 Est. Cost/Share $16.89 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 3.8%
Value $44.84M Shares 4,965,513 Share Price $9.03 Est. Cost/Share $18.43 Unrealized @ Report Date —
— KALA PHARMACEUTICALS INC 3.3%
Value $39.07M Shares 2,113,236 Share Price $18.49 Est. Cost/Share $22.84 Unrealized @ Report Date —
— MYOVANT SCIENCES LTD 3.0%
Value $35.78M Shares 2,830,455 Share Price $12.64 Est. Cost/Share $12.11 Unrealized @ Report Date —
— SCPHARMACEUTICALS INC 2.9%
Value $34.54M Shares 2,857,143 Share Price $12.09 Est. Cost/Share $12.09 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 2.9%
Value $34.3M Shares 6,984,692 Share Price $4.91 Est. Cost/Share $7.39 Unrealized @ Report Date -34.5%
— KADMON HLDGS INC 1.9%
Value $22.7M Shares 6,269,342 Share Price $3.62 Est. Cost/Share $3.35 Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 1.6%
Value $19.53M Shares 900,000 Share Price $21.70 * Est. Cost/Share $14.72 Unrealized @ Report Date 0.0%
— ENDOCYTE INC 1.2%
Value $14.4M Shares 3,364,648 Share Price $4.28 Est. Cost/Share $4.28 Unrealized @ Report Date —
SPRO SPERO THERAPEUTICS INC 1.2%
Value $14.4M Shares 1,225,647 Share Price $11.75 * Est. Cost/Share $12.27 Unrealized @ Report Date 0.0%
— AVEO PHARMACEUTICALS INC 1.2%
Value $14.13M Shares 5,062,759 Share Price $2.79 Est. Cost/Share $2.59 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 1.2%
Value $14.05M Shares 1,441,070 Share Price $9.75 * Est. Cost/Share $9.16 Unrealized @ Report Date +13.6%
— RA PHARMACEUTICALS INC 1.0%
Value $11.49M Shares 1,351,808 Share Price $8.50 Est. Cost/Share $15.19 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 1.0%
Value $11.43M Shares 3,096,840 Share Price $3.69 Est. Cost/Share $3.69 Unrealized @ Report Date —
— CLEMENTIA PHARMACEUTICALS INC COM NPV 0.9%
Value $11.11M Shares 585,403 Share Price $18.98 Est. Cost/Share $16.89 Unrealized @ Report Date —
KRYS KRYSTAL BIOTECH INC 0.6%
Value $7.364M Shares 700,000 Share Price $10.52 * Est. Cost/Share $10.08 Unrealized @ Report Date -0.6%
ARGX ARGENX SE 0.4%
Value $4.787M Shares 75,816 Share Price $63.14 Est. Cost/Share $63.14 Unrealized @ Report Date —
— G1 THERAPEUTICS INC 0.3%
Value $3.17M Shares 159,780 Share Price $19.84 Est. Cost/Share $17.44 Unrealized @ Report Date —
— PROTEON THERAPEUTICS INC 0.2%
Value $2.541M Shares 1,337,462 Share Price $1.90 Est. Cost/Share $1.53 Unrealized @ Report Date —
— CHIASMA INC 0.2%
Value $2.001M Shares 1,176,806 Share Price $1.70 Est. Cost/Share $2.55 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS INC 0.1%
Value $1.687M Shares 585,890 Share Price $2.88 Est. Cost/Share $6.18 Unrealized @ Report Date —